Towards Safer Therapies
In the heart of the science and business location Heidelberg, GeneWerk GmbH has found ideal conditions for steady growth. For six years, the company with its experienced and motivated staff has been offering NGS-based molecular biological analysis services, especially for companies in the pharmaceutical, life sciences and biotechnology industries.
The aim is to advance the development of innovative therapies such as gene and immunotherapies through comprehensive safety analyses. Safe and effective therapies are thus
within reach for many diseases.
With the help of the investor Ampersand Capital Partners, GeneWerk will push ahead with its expansion in the USA in order to better serve the rapidly growing American market.
We are looking for a new team member to join a great team as soon as possible in Heidelberg:
Our service is based on molecular analysis of DNA and RNA combined with Next Generation Sequencing (NGS). Our global customers are pharmaceutical companies that value the highest quality standards. The tasks as part of the bioinformatics in detail are:
What We Offer (i.a.):
We are looking forward to receiving your comprehensive application.
We are also happy to answer questions on the phone: +49 6221 42790-13 | Contact Person: Luisa Wassermann, Management Assistant
Contract Type: Full Time